Just Other Articles

Some companies' Achilles' heels are their accounts receivables, poor credit control or weak administration of credit policy. These weaknesses can smolder the companies of their vital lifeline - cash flow causing them t

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

o asphyxiate.

In the construction industry, it is common for many contractors to run into problems with the receivables. Although the accounting practices allow for recognition of the profits from the receivables befo

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

e the money is collected as the progressive payment is due, these receivables do not constitute cash flow. When the construction industry encountered doldrums a few years ago, many small contractors folded up even thou

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

h they had substantial amounts of receivables.

The problem arose out of non-payments by the main contractors, owners and developers. In Singapore, the construction industry is going through a bad patch. Projects are o

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ten clinched at a loss and quite often the receivables are not collectible. Also, in some contracts, the last retention amount or progressive payment is not collectible as the owner will give excuses for non-payments d

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e to disputes. It ends up with protracted litigations which further drain the cash flow of these contractors.

The Singapore government is trying to improve the situation by enforcing laws that government agencies and

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

owners must promptly pay up the dues and not delay or drag payments unnecessarily. In China, the national triangular debt problem is prevalent. It is basically a problem of bad receivables. Some 30% of the loans of Chi

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

a's four major banks are not being serviced by borrowers. In addition, many so-called profitable companies have high receivables but most of the money cannot be collected as the customers default on payments. The gover

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ment had tried to address this problem by transferring the bad loans to a special asset company for recovery. The government had announced additional measures in April 2004 to cool down the overheated economy. The driv

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

rs of China's phenomenal economic growth have altered somewhat over the past twenty years. In the initial years of the 1980s, the emphasis was on the reforms of the township and state-owned enterprises (SOEs) reform to

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

facilitate their adaptations to the market changes.

Towards the late 1980s, the central government alleviated the economic burden of the SOEs by allowing them to tap the capital market for funds. These were done throu

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

gh share and bond issues to workers. However, in the early 1990s, Vice Premier Zhu Ronji adopted the macroeconomic control policies to curb the high inflation in China. Such tight monetary policy caused the further det

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rioration in the financial situation of the SOEs, particularly those which had borrowed heavily from other SOEs or state-owned banks. Consequently, this worsened the triangular debt problem, prompting the urgent need t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

reorganise the banking system in 1995. During this period, the Beijing administration gave quotas to provinces to allow SOEs to go public.

To alleviate the pressures of minimising local unemployment and to fulfil the

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

technical requirement of three years of profits, the provincial governors were prompted to give the quota to those inefficient SOEs which were in dire need of money instead of efficient SOEs. This is the equivalence of

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

throwing good money to chase after bad money. The flotation of shares of these SOEs become a "bubble" problem which can explode at any time. Receivables were the fundamental problem for the Chinese stateowned banks and

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

the SOEs. The government should have bitten the bullet, closed down these inefficient operations. However, they were allowed to continue to operate for fear of creating unemployment and other social and political prob

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ems.

Thus the healthy companies were also dragged into the "triangular debt", the casualty of being too casual with their receivables. Oftentimes, debtors who are unable to pay may give the ruse that it is a principle

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

over some disagreements that cause them not to pay and not the money issue. However, you can be sure that in most cases, the reason for not paying is always the money and not the principle. And the principle for you to

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

note is to collect the money first. Therefore, making a sale is not enough. The seller has to make sure that the money can be collected. You cannot pay your staff with receivables, you can only pay your staff with cash

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/13903/justotherarticles-Casual-With-Receivables-You-May-Land-Up-as-a-Casualty.html">Casual With Receivables, You May Land Up as a Casualty</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/13903/justotherarticles-Casual-With-Receivables-You-May-Land-Up-as-a-Casualty.html]Casual With Receivables, You May Land Up as a Casualty[/url]

People who have a chip on their shoulder manage to hurt everyone around them. Their attitude of disrespect and lack of team work makes others work harder and pick up the slack. It's immaturity at it's worst, and it's harmful for any organization. Hopefully, if people recognize their own bad attitudes and seek to correct them, the whole department can improve.

The value of being known in your industry as an expert is measurable-through increased sales, promotions, and media attention. Establish yourself as an expert and see the differences it can make.

Preparing for a job interview is the point in the job search where many people get lazy and neglect to do everything they can to get ready for it. If you’re getting to the interview stage but can’t seem to get further than the first round of interviews, there are several things you might be doing wrong.

Tags

Links

Just Other Articles - Casual With Receivables, You May Land Up as a Casualty

Related Articles: